Effects of Cultura Yoghurt in Relation to Transit Time and Digestive Discomfort in Healthy Women and Men

NCT ID: NCT01102036

Last Updated: 2011-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the effect of cultura yoghurt on transit time and digestive discomfort during 2 weeks of treatment in comparison to placebo in healthy women and men.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transit time is the time it takes for a substance to pass through the gut. The major part of the transit is spent in the large bowel is therefore mainly a colonic event. It has been observed that slow transit time is associated with high prevalence of large bowel disorders. The objectives of this study is to:

* determine the effect on mean transit time after 2 weeks intake of a investigational products using radio-opaque sulphate impregnated polyethylene pellets as markers.
* determine effect of investigational products on total symptom score according to Bristol Stool Form (BSF)
* determine effect of investigational products in gastrointestinal symptoms
* determine safety of intake of the investigational products

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Yoghurt without probiotics

Yoghurt without probiotic bacteria

Group Type PLACEBO_COMPARATOR

Yoghurt without probiotics

Intervention Type OTHER

Yoghurt without probiotics

Cultura yoghurt

Cultura yoghurt with L casei F19, acidophilus La5 adn B lactis Bb 12

Group Type ACTIVE_COMPARATOR

Cultura L casei F19, acidophilus La5 , B lactis Bb 12

Intervention Type OTHER

2 weeks consumption,250 ml/day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cultura L casei F19, acidophilus La5 , B lactis Bb 12

2 weeks consumption,250 ml/day

Intervention Type OTHER

Yoghurt without probiotics

Yoghurt without probiotics

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cultura probiotic yoghurt Yoghurt without prbiotics

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female and Males
* Healthy
* BMI 19-29 at visit 1
* Age 18 and 60 years at visit 1
* Defecation 3-4 times per week or every second to third day (Bristol Stool Form) during the run-in
* Transit time 35 and 72 hours calculated from the abdominal X-ray at visit 3
* Signed written informed consent

Exclusion Criteria

* Use of probiotics food or supplements during the study
* Past history of digestive disease
* Previous complicated GI surgery
* Oral use of antimicrobial medication or antimicrobial prophylaxis 4 weeks prior to screening visit
* Use of laxatives (medication or dietary supplements) during the study.
* Pregnant or lactating or wish to become pregnant during the period of the study
* Lack of suitability for participation in the trial, for any reason, as judged by the personnel at KPL Good Food Practice AB
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arla Foods

INDUSTRY

Sponsor Role collaborator

Good Food Practice, Sweden

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Birgitta Sundberg

Director clinical trials

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lars Magnusson, CEO

Role: STUDY_DIRECTOR

Good Food Practice, Uppsala, Sweden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Good Food Practice

Uppsala, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-X-Ray U-09-017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Probiotic on Constipation
NCT03100851 COMPLETED PHASE3
Consumption of Milk Drink and Constipation
NCT02091115 COMPLETED PHASE1/PHASE2